FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 251 through 265 of 265

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
VRCA Nasdaq Verrica Pharmaceuticals Inc. 2830
VRDN Nasdaq Viridian Therapeutics, Inc. 2830
VSTM Nasdaq Verastem, Inc. 2830
VTGN Nasdaq Vistagen Therapeutics, Inc. 2830
VTRS Nasdaq Viatris Inc. 2830
VTYX Nasdaq Ventyx Biosciences, Inc. 2830
WVE Nasdaq Wave Life Sciences Ltd. 2830
XBIO Nasdaq Xenetic Biosciences, Inc. 2830
XERS Nasdaq Xeris Biopharma Holdings, Inc. 2830
XOMA Nasdaq XOMA Royalty Corporation 2830
YCBD NYSE American cbdMD, Inc. 2830
ZEOX Over the counter Zeo ScientifiX, Inc. 2830
ZLAB Nasdaq Zai Lab Limited 2830
ZVRA Nasdaq Zevra Therapeutics, Inc. 2830
ZYBT Nasdaq Zhengye Biotechnology Holding Limited 2830
Results 250 through 265 of 265